Mrna therapy for arm swelling after breast cancer
Part of Cancer, Skin clinical trials.
This study tests a new mRNA therapy given as an injection to help restore lymphatic flow and reduce arm swelling in women with lymphedema after breast cancer treatment. If you have had moderate arm swelling for at least 6 months and are otherwise healthy, you might be eligible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older.
- You had breast cancer that is hormone receptor positive (HR+), not HER2 positive or triple negative.
- You developed lymphedema (arm swelling) more than 5 years after your breast cancer surgery.
- Your arm swelling is moderate: about 20-40% bigger than your healthy arm.
- You wear a compression sleeve daily as part of your lymphedema care.
- You do not have active cancer, metastatic disease, or other serious health conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a new procedure meant to lower the chance of getting lymphedema (arm swelling) after breast cancer surgery that removes lymph nodes in the armpit. It may help patients reduce the risk of long-term arm swelling, especially after lymph node dissection.
This trial studies whether a specific surgery (a lymph vessel transplant) can reduce upper-arm lymphedema in people who developed swelling after breast cancer treatment. You must already have tried standard therapy and still have persistent, mild-to-moderate swelling.
This trial studies a specialized lymph surgery (called VLNT, moving lymph tissue) to treat swelling in an arm caused by breast cancer treatment. It may help reduce lymphedema that doesn’t fully improve with compression and elevation.
This study looks at a combination treatment to improve swelling in one arm caused by lymphedema. You may be a good candidate if your arm swelling has not fully improved with standard compression therapy and you are able to have surgery.
This study tests a surgical procedure (called supermicrosurgical lymphaticovenous anastomosis, or LVA) that connects tiny lymph vessels to nearby veins. The goal is to prevent arm swelling (lymphedema) in women with breast cancer who are having lymph nodes removed and radiation therapy.
This study looks at ways to prevent arm swelling (lymphedema) related to breast cancer after surgery to remove lymph nodes. It may help people who are getting axillary lymph node dissection lower the chance of long-term swelling.
Hear when a new Secondary Lymphedema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.